Fri, Apr 4, 2025
Volume 18, Issue 4 (Jul-Aug 2024)
mljgoums 2024, 18(4): 5-7 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fabin M, Jayakumar J, Shanker S. Platelet-to-lymphocyte ratio: A useful predictor of glycemic control in patients with diabetes mellitus. mljgoums 2024; 18 (4) :5-7
URL: http://mlj.goums.ac.ir/article-1-1791-en.html
URL: http://mlj.goums.ac.ir/article-1-1791-en.html
1- Department of Emergency Medicine, KMCT Medical College, Mukkam, Kerala, India
2- Department of Radiology, KMCT Medical College, Mukkam, Kerala, India
3- Department of Pathology, KMCT Medical College, Mukkam, Kerala, India ,swathyshanker.ss@gmail.com
2- Department of Radiology, KMCT Medical College, Mukkam, Kerala, India
3- Department of Pathology, KMCT Medical College, Mukkam, Kerala, India ,
Abstract: (954 Views)
Background: Diabetes Mellitus (DM) is a metabolic disorder whose pathophysiology has been linked to various genetic and environmental factors. The main mechanism of the development of complications has been implicated as inflammation-mediated. Various blood cell parameters are being used as early indicators of inflammation-mediated endothelial dysfunction; thereby predicting the severity or prognosis of DM. In this study, we aimed to evaluate the role of platelet-to-lymphocyte ratio (PLR) in predicting glycemic control in patients with DM.
Methods: This is a retrospective, hospital-based study conducted from August 2023 to December 2023. A total of 134 patients were included in the study. The hematological and biochemical reports of the study population were retrieved, and the data obtained was analyzed using SPSS software version 16.0.
Results: In this study, it has been found that PLR is significantly increased in patients suffering from DM with poor glycemic control compared to those patients with good glycemic control (P<0.001). In concordance with other studies, a positive association was observed between PLR and disease severity.
Conclusion: Based on the findings of the study, PLR may be used as a predictive marker in assessing the severity and prognosis of DM; however, the exact cut-off value is yet to be determined.
Methods: This is a retrospective, hospital-based study conducted from August 2023 to December 2023. A total of 134 patients were included in the study. The hematological and biochemical reports of the study population were retrieved, and the data obtained was analyzed using SPSS software version 16.0.
Results: In this study, it has been found that PLR is significantly increased in patients suffering from DM with poor glycemic control compared to those patients with good glycemic control (P<0.001). In concordance with other studies, a positive association was observed between PLR and disease severity.
Conclusion: Based on the findings of the study, PLR may be used as a predictive marker in assessing the severity and prognosis of DM; however, the exact cut-off value is yet to be determined.
Research Article: Research Article |
Subject:
bacteriology
Received: 2024/03/11 | Accepted: 2024/06/10 | Published: 2025/03/11 | ePublished: 2025/03/11
Received: 2024/03/11 | Accepted: 2024/06/10 | Published: 2025/03/11 | ePublished: 2025/03/11
References
1. Ministry of Health and Family Welfare. Update on treatment of Diabetes. August 2023. [View at Publisher]
2. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015 Jun 25;6(6):850-67. doi: 10.4239/wjd.v6.i6.850 [View at Publisher] [DOI] [PMID] [Google Scholar]
3. Priyanka Garg, Navneet Duggal. Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review. Obesity Medicine. 2022; 35. ISSN 2451-8476. [View at Publisher] [DOI] [Google Scholar]
4. Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021; 69(11): 2932-2938. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14: 173-94. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Almalki ZS, Ahmed NJ, Alahmari AK, Alshehri, Ahmed M, Alyahya SA, et al. Identifying the risk factors and the prevalence of poor glycemic control among diabetic outpatients in a rural region in Saudi Arabia. Int J Pharm Res. 2021:15-23. [View at Publisher] [DOI] [Google Scholar]
7. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors 2001. JAMA. 2003; 289(1):76-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Aronson D, Edelman ER. Coronary Artery Disease and Diabetes Mellitus. Heart Fail Clin. 2016; 12(1): 117-33. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Razmaria, A.A. Diabetic neuropathy. JAMA. 2015; 314(20): 2202. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107(9): 1058-70. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115(12): 3378‐3384. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Rübsam A, Parikh S, Fort P. Role of inflammation in diabetic retinopathy. International journal of molecular sciences. Int J Mol Sci. 2018; 19: 4. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Onalan E., Gozel N., Donder E. Can hematological parameters in type 2 diabetes predict microvascular complication development? Pak. J. Med. Sci. 2019; 35(6): 1511. [View at Publisher] [DOI] [PMID] [Google Scholar]
14. Liu N, Sheng J, Pan T, Wang Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in Chinese patients with type 2 diabetes. Clin Lab. 2019 ;65(3): 325. [View at Publisher] [DOI04] [PMID] [Google Scholar]
15. Zhang K, Ding S, Lyu X, Tan Q, Wang Z. Correlation between the platelet-to-lymphocyte ratio and diabetic foot ulcer in patients with type 2 diabetes mellitus. J Clin Lab Anal. 2021; 35(4): e23719. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 1992; 2019(65): 38-42. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Moursy EY, Megallaa MH, Mouftah RF, Ahmedet SM. Relationship Between Neutrophil-Lymphocyte Ratio and Microvascular Complications in Egyptian Patients with Type 2 Diabetes. American J Inter Med. 2015; 3(6): 250-255. [View at Publisher] [DOI] [Google Scholar]
18. Mertoglu C, Gunay M. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diab Met Syndr Clin Res Rev. 2016; 11(1): S127-S131. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Yue S, Zhang J, Wu J, Wu J, Teng W, Liu L, et al. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015; 12(8): 10009-10019. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Wang JR, Chen Z, Yang K, Yang HJ, Tao WY, Li YP, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 12, 55 (2020). [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Li L, Shen Q, Rao S. Association of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study. Ther Clin Risk Manag. 2022;18: 1157-1166 [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Duan S, Sun L, Zhang C, Wu L, Nie G, Huang Z, et al. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease. Int Immunopharmacol. 2021; 93: 107413. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Kamrul-Hasan ABM, Mustar Marufa,Asaduzzaman MD,et al. Evaluation of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Markers of Diabetic Kidney Disease in Bangladeshi Patients with Type 2 Diabetes Mellitus. Journal of Diabetology. 2021; 12(1): 58-62. [View at Publisher] [DOI] [Google Scholar]
24. Du L, Hu X, Zhang B, Miao X, Wang J, Shen J, et al. The relationship of platelet-to-lymphocyte ratio with cognitive decline in T2DM. Diabetol Metab Syndr 2021; 13(1): 151. [View at Publisher] [DOI] [PMID] [Google Scholar]
25. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med. 2019; 39(4): 345-357. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Enamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.